e-learning
resources
Vienna 2003
Sunday 28.09.2003
Non-steroidal drugs in the treatment of respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New perspectives of basic aspirin-induced asthma therapy
H. V. Evsyukova (St Petersburg, Russia)
Source:
Annual Congress 2003 - Non-steroidal drugs in the treatment of respiratory diseases
Session:
Non-steroidal drugs in the treatment of respiratory diseases
Session type:
Thematic Poster Session
Number:
723
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. V. Evsyukova (St Petersburg, Russia). New perspectives of basic aspirin-induced asthma therapy. Eur Respir J 2003; 22: Suppl. 45, 723
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
New frontiers in the management of asthma
Source: International Congress 2017 – State of the art session: "Paediatric"
Year: 2017
IgE-mediated asthma: New revelations and future insights
Source: International Congress 2015 – IgE-mediated asthma: New revelations and future insights
Year: 2015
New treatments in severe paediatric asthma
Source: International Congress 2017 – PG7 Paediatric asthma
Year: 2017
New aspects of COPD ethiopathogenesis
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
New and future developments of therapy for asthma in children
Source: Eur Respir Mon 2012; 56: 224-234
Year: 2012
Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives
Source: Eur Respir Rev 2015; 24: 594-601
Year: 2015
Update on basic research on airway inflammation in asthma
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012
New drugs for severe asthma – what should we target and how?
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014
The basic science behind asthma biologics
Source: International Congress 2018 – New biologics for asthma: which patients, which agents, which results, at what cost?
Year: 2018
Principles of antileucotrien therapy at allergic rhinitis and chronicle adenoiditis
Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management
Year: 2010
New instrument of mild asthma management
Source: Annual Congress 2010 - Medical education
Year: 2010
Do we need new therapies for noneosinophilic asthma?
Source: Annual Congress 2004 - Noneosinophilic asthma
Year: 2004
New genetics and epigenetics insights in paediatric asthma
Source: International Congress 2017 – Omics in paediatric asthma and beyond
Year: 2017
Recommended new therapies for severe asthma and the future
Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop
Year: 2014
Biologic therapies in paediatric severe asthma
Source: ERS webinar 2020: Biologic therapies in paediatric severe asthma
Year: 2020
Recommendations of new therapies for severe asthma and the future
Source: Annual Congress 2013 –ERS/ATS Task Force report on severe asthma
Year: 2013
Current opinion: Pharmacological approaches in asthma and COPD
Source: Breathe 2009; 6: 24-35
Year: 2009
New targets for drug development in asthma
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept